Saturday 27 April 2013

Global Pharmaceutical & Biotechnology Outlook 2013 Mature Biotech - Reports Corner


For complete information about the report, please visit our website

https://www.reportscorner.com/reports/10017/Global-Pharmaceutical-&-Biotechnology-Outlook-2013:-Mature-Biotech/

Profitable Biotech (Mature Biotech) and non-Profitable Biotech companies (Rising stars) have developed innovative drugs for treatment of chronic and non chronic diseases. In the next five years the distinction between mature biotech companies and large global pharma is likely to disappear as investment in R&D and acquisition start delivering and Market Cap match the large global pharma.


No comments:

Post a Comment